SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$18.08
+0.93 (+5.42%)
Performance
1D
—
1W
—
1M
—
3M
+20.77%
6M
-5.64%
1Y
-28.42%
YTD
+3.20%
Open$17.46
Previous Close$17.15
Day High$18.15
Day Low$17.06
52W High$30.98
52W Low$13.83
Volume—
Avg Volume5.60M
Market Cap13.31B
P/E Ratio—
EPS$-1.01
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.75
Above
SMA 200
$20.83
Below
RSI (14)
54
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
23 analysts
Price Target
+984.5% upside
Current
$18.08
$18.08
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |